Drug Profile
Mecasermin - Ipsen
Alternative Names: FK 780; IGF-1; Increlex; Insulin-like growth factor-1; rhIGF-I; Somatomedin-1Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Genentech
- Developer Ipsen; Ipsen Biopharmaceuticals; Tercica
- Class Antihyperglycaemics; Growth factors; Peptides
- Mechanism of Action Insulin-like growth factor I stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Short stature
- Discontinued Diabetes mellitus